Latest Insider Transactions at Sutro Biopharma, Inc. (STRO)
This section provides a real-time view of insider transactions for Sutro Biopharma, Inc. (STRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SUTRO BIOPHARMA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SUTRO BIOPHARMA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 05
2020
|
Trevor Hallam Pres. Rsrch & Cf. Sctific Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
9,182
+20.01%
|
$36,728
$4.36 P/Share
|
|
Oct 01
2018
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
666,666
+19.66%
|
$9,999,990
$15.0 P/Share
|
|
Oct 01
2018
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,056,843
+50.0%
|
-
|